% Expired Patents = 14.3

EPO Patents = 2

Forward Citations = 10

Loading Chart...

3 inventors (with patents filed for the assignee):

Amotz Shemi (7 out of 9 patents)

Elina Zorde Khvalevsky (6 out of 6 patents)

Rachel Malka Gabai (3 out of 3 patents)

7 patents: Sort by Forward Citations

1. 10006030 - RNA interference compositions targeting heat shock protein 90 and methods of use thereof (2018-06-26),

2. 9764035 - Methods and compositions for treating prostate cancer (2017-09-19),

3. 9687500 - Methods and compositions for treating cancer (2017-06-27),

4. 9080173 - Methods and compositions for RNAi-based cancer treatment (2015-07-14),

5. 9006199 - Methods and compositions for treating prostate cancer (2015-04-14),

6. 8999945 - Methods, compositions and systems for local delivery of drugs (2015-04-07),

7. 8889642 - Methods and compositions for RNAi-based cancer treatment (2014-11-18),

Silenseed Ltd. is a biotechnology company focused on developing innovative solutions for cancer treatment. Using their proprietary technology, they are able to deliver targeted therapy directly to cancer cells, minimizing side effects and improving patient outcomes. Their mission is to revolutionize cancer treatment through precision medicine and personalized therapies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

7 Patents

#8 in Modiin

#910 in Israel

Modiin, Israel

Silenseed Ltd.

Forward Citations = 10

3 inventors:

Amotz Shemi (7 out of 9 patents)

Elina Zorde Khvalevsky (6 out of 6 patents)

Rachel Malka Gabai (3 out of 3 patents)

Please report any incorrect information to [email protected]

2 patents (EPO):

Please report any incorrect information to [email protected]